机构

• 上海药物研究所 [4]
• 合肥物质科学研究院 [3]

采集方式

• OAI收割 [7]

内容类型

• 期刊论文 [7]

发表日期

• 2022 [7]

学科主题

筛选

浏览/检索结果: 共7条，第1-7条 帮助 限定条件 发表日期：2022     条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 Targeting PI3K alpha overcomes resistance to KRas(G12C) inhibitors mediated by activation of EGFR and/or IGF1R 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2022, 页码: 12 作者:  Qi, Wei-liang;  Li, Hui-yu;  Wang, Yi;  Xu, Lan;  Deng, Jie-ting   |  收藏  |  浏览/下载：15/0  |  提交时间：2023/04/10 AMG510  KRas(G12C)  PI3K  drug resistance  combination therapy   Duplex real-time fluorescent recombinase polymerase amplification for the rapid and sensitive detection of two resistance genes in drug-resistant Staphylococcus aureus 期刊论文  OAI收割 JOURNAL OF MICROBIOLOGICAL METHODS, 2022, 卷号: 202 作者:  Shi, Zhonglin;  Li, Yanan;  Hu, Anzhong;  Cui, Junsheng;  Shao, Min   |  收藏  |  浏览/下载：24/0  |  提交时间：2022/12/23 Drug -resistant Staphylococcus aureus  ermA  mecA  Recombinase polymerase amplification  Resistance genes   Drug Degradation Caused by mce3R Mutations Confers Contezolid (MRX-I) Resistance in Mycobacterium tuberculosis 期刊论文  OAI收割 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 卷号: 66, 期号: 10, 页码: 11 作者:  Pi, Rui;  Chen, Xiaomin;  Meng, Jian;  Liu, Qingyun;  Chen, Yiwang   |  收藏  |  浏览/下载：27/0  |  提交时间：2022/11/11 Mycobacterium tuberculosis  drug resistance  contezolid  Mce3R  Rv1936  degradation  drug resistance mechanisms   Discovery of novel heteroaryl alkynes for highly potent KITD816V cells inhibition to treat gastrointestinal stromal tumors 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2022, 卷号: 12, 期号: 10, 页码: 4004-4007 作者:  Xie, Zhicheng;  Li, Lin;  Guo, Yihao;  Zhang, Mi;  Chen, Taiwen   |  收藏  |  浏览/下载：20/0  |  提交时间：2022/12/13 KITD816V cells  Mutation  Drug resistance  Gastrointestinal stromal tumors   Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies 期刊论文  OAI收割 FRONTIERS IN PHARMACOLOGY, 2022, 卷号: 13 作者:  Wu, Xiaofan;  Yang, Hongjian;  Yu, Xingfei;  Qin, Jiang-Jiang   |  收藏  |  浏览/下载：25/0  |  提交时间：2022/12/22 HER2  breast cancer  targeted therapy  drug resistance  overcoming strategies   CHMFL-26 is a highly potent irreversible HER2 inhibitor for use in the treatment of HER2-positive and HER2-mutant cancers 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2022 作者:  Cao, Jiang-yan;  Qi, Shuang;  Wu, Hong;  Wang, Ao-li;  Liu, Qing-wang   |  收藏  |  浏览/下载：53/0  |  提交时间：2022/03/28 HER2  breast cancers  gastric cancers  irreversible inhibitor  drug resistance   The PROTAC selectively degrading Bcl-x(L) represents a novel Hedgehog pathway inhibitor with capacity of combating resistance to Smoothened inhibitors while bone 期刊论文  OAI收割 THERANOSTICS, 2022, 卷号: 12, 期号: 17, 页码: 7476-7490 作者:  Zhang, Shaoqing;  Chen, Yue;  Xu, Zhongli;  Yang, Jun;  Sun, Renhong   |  收藏  |  浏览/下载：7/0  |  提交时间：2023/04/10 Hedgehog  Bcl-xL  PROTAC  drug resistance  bone growth